Tirzepatide / Glycine
Maximum weight loss
Tirzepatide is a once-weekly injection and the first dual GLP-1 / GIP receptor agonist. In clinical trials, it produced the most significant weight loss results of any FDA-approved medication to date — averaging up to 22.5% of total body weight over 72 weeks. Compounded with glycine for smoother tolerability.
- Free expedited shipping
- FSA / HSA eligible
- Licensed physicians
Choose your tirzepatide / glycine plan
All packages include physician oversight, free expedited shipping, and ongoing dose adjustments.
How Tirzepatide / Glycine works
Tirzepatide activates two gut hormone receptors (GLP-1 and GIP) that regulate appetite, blood sugar, and how your body stores fat. It slows gastric emptying so you feel full sooner, reduces food noise, and improves insulin sensitivity.
What to expect
- Average 15–22% total body weight loss over 12 months
- Significant reduction in appetite and food cravings
- Improved A1C and blood sugar control
- Lowered cardiovascular risk markers (LDL, triglycerides, blood pressure)
- Reduced visceral fat and improved waist-to-hip ratio
- Better sleep quality as weight comes down
- Improved insulin sensitivity and metabolic flexibility
- Less 'food noise' — fewer intrusive thoughts about eating
- Compounded by PCAB-accredited US pharmacies
Dosing & schedule
- Form
- Subcutaneous injection
- Frequency
- Once weekly
- Duration
- Ongoing, with regular check-ins
Which dose is right for you?
Tirzepatide is started low and increased gradually so your body adjusts with minimal side effects. Most members move up one step every 4 weeks based on how they're tolerating it and how their weight loss is progressing. Your clinician makes the final call — this is a typical roadmap, not a fixed prescription.
- 1Weeks 1–42.5 mg / weekStarter dose — your body adjusts. Not intended for weight loss yet.
- 2Weeks 5–85 mg / weekFirst therapeutic dose. Appetite suppression usually kicks in here.
- 3Weeks 9–127.5 mg / weekStep up if weight loss has stalled and side effects are mild.
- 4Weeks 13–1610 mg / weekCommon maintenance dose for many members.
- 5Weeks 17–2012.5 mg / weekOptional step up for continued progress.
- 6Week 21+15 mg / week (max)Maximum dose — reserved for members who need it for goal weight.
Tip: Most people don't need the maximum dose. Stay at the lowest dose that's still delivering results — it minimizes side effects and cost.
For educational purposes only. Your Rejuviya clinician determines your actual starting dose and titration plan during intake.
Your expected journey
- 01Week 1–4
Reduced appetite and food noise; 2–5 lb loss.
- 02Month 2–3
Noticeable changes in clothing fit; 5–10% body weight reduction.
- 03Month 6+
Meaningful long-term loss — average 15%+ with consistent use.
Possible side effects
Your provider screens for risk factors before prescribing and monitors throughout treatment.
- Nausea (most common, usually mild and transient)
- Constipation or diarrhea
- Fatigue during dose escalation
- Rare: pancreatitis, gallbladder issues — flagged in screening
About Tirzepatide / Glycine
It's the same active ingredient (tirzepatide), compounded by a licensed US pharmacy to your prescribed dose.
